Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Vivos Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 30 | 27 | −3 |
| Shares | 2.12M | 1.57M | −558.3K (−26.3%) |
| Value | $1.38M | $629.7K | −$749.3K (−54.3%) |
New holders (3)
Institutions that held Vivos Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lincoln National Corp | 14,817 | $5.96K | 0.00% |
| Two Sigma Securities, LLC | 12,213 | $4.91K | 0.00% |
| Bank of America Corp | 46 | $18 | 0.00% |
Sold out (6)
Institutions that held Vivos Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Russell Investments Group, Ltd. | 365,901 | $236.0K |
| Boston Partners | 78,454 | $51.0K |
| Susquehanna International Group, LLP | 41,487 | $27.0K |
| SeaCrest Wealth Management, LLC | 40,000 | $26.0K |
| Wagner Wealth Management, LLC | 2,000 | $1.00K |
| Simplex Trading, LLC | 923 | $0 |